Ravi Kurukulasuriya

Person

Gurnee, IL, US

People

Patents Grantslast 30 patents

Information Patent Grant
Treatment of central nervous system disorders
- Patent number 9,464,072
- Issue date Oct 11, 2016
- AbbVie Inc.
- R. Scott Bitner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
- Patent number 8,993,632
- Issue date Mar 31, 2015
- AbbVie Inc.
- R. Scott Bitner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of central nervous system disorders
- Patent number 8,940,902
- Issue date Jan 27, 2015
- AbbVie Inc.
- R. Scott Bitner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
- Patent number 8,198,331
- Issue date Jun 12, 2012
- Abbott Laboratories
- R. Scott Bitner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
- Patent number 7,737,137
- Issue date Jun 15, 2010
- Abbott Laboratories
- Michael E. Brune
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of the 11-β-hydroxysteroid dehydrogenase type 1 enzyme
- Patent number RE41135
- Issue date Feb 16, 2010
- Abbott Laboratories
- Jeffrey J. Rohde
- 564 - Organic compounds
Information Patent Grant
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
- Patent number 7,528,282
- Issue date May 5, 2009
- Abbott Laboratories
- Jeffrey J. Rohde
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
- Patent number 7,435,833
- Issue date Oct 14, 2008
- Abbott Laboratories
- Vince S. Yeh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
- Patent number 7,217,838
- Issue date May 15, 2007
- Abbott Laboratories
- Jeffrey J. Rohde
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the preparation of matrix metalloproteinase inhibitors
- Patent number 6,441,189
- Issue date Aug 27, 2002
- Abbott Laboratories
- Anne E. Bailey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the selective N-formylation of N-hydroxylamines
- Patent number 6,350,902
- Issue date Feb 26, 2002
- Abbott Laboratories
- David R. Hill
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME
- Publication number 20150265613
- Publication date Sep 24, 2015
- ABBVIE INC.
- R. Scott Bitner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
- Publication number 20150099740
- Publication date Apr 9, 2015
- ABBVIE INC.
- R. Scott Bitner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
- Publication number 20130059829
- Publication date Mar 7, 2013
- R. Scott Bitner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
- Publication number 20120289512
- Publication date Nov 15, 2012
- Abbott Laboratories
- R. Scott Bitner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
- Publication number 20100152179
- Publication date Jun 17, 2010
- Abbott Laboratories
- R. Scott Bitner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME
- Publication number 20090176783
- Publication date Jul 9, 2009
- Abbott Laboratories
- R. Scott Bitner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
- Publication number 20090054426
- Publication date Feb 26, 2009
- Abbott Laboratories
- R. Scott Bitner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibitors of the 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Enzyme
- Publication number 20080312214
- Publication date Dec 18, 2008
- Abbott Laboratories
- Vince S. Yeh
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME
- Publication number 20080076819
- Publication date Mar 27, 2008
- Abbott Laboratories
- Vince S. Yeh
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME
- Publication number 20070179186
- Publication date Aug 2, 2007
- Jeffrey J. Rohde
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
- Publication number 20060149070
- Publication date Jul 6, 2006
- Jeffrey J. Rohde
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Glucagon receptor antagonists/inverse agonists
- Publication number 20040209928
- Publication date Oct 21, 2004
- Ravi Kurukulasuriya
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Process for the preparation of matrix metalloproteinase inhibitors
- Publication number 20020052511
- Publication date May 2, 2002
- Anne E. Bailey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for the preparation of matrix metalloproteinase inhibitors
- Publication number 20020019539
- Publication date Feb 14, 2002
- Anne E. Bailey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for the selective N-formylation of N-hydroxylamines
- Publication number 20020002307
- Publication date Jan 3, 2002
- David R. Hill
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Process for the selective N-formylation of N-hydroxylamines
- Publication number 20010031896
- Publication date Oct 18, 2001
- David R. Hill
- C07 - ORGANIC CHEMISTRY

Ravi Kurukulasuriya

Person

Patents Grantslast 30 patents

Treatment of central nervous system disorders

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

Treatment of central nervous system disorders

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme

Inhibitors of the 11-β-hydroxysteroid dehydrogenase type 1 enzyme

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

Process for the preparation of matrix metalloproteinase inhibitors

Process for the selective N-formylation of N-hydroxylamines

Patents Applicationslast 30 patents

INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME

TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS

TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme

TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS

INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME

TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS

Inhibitors of the 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Enzyme

INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME

INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

Glucagon receptor antagonists/inverse agonists

Process for the preparation of matrix metalloproteinase inhibitors

Process for the preparation of matrix metalloproteinase inhibitors

Process for the selective N-formylation of N-hydroxylamines

Process for the selective N-formylation of N-hydroxylamines